DE60113895D1 - Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose - Google Patents

Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose

Info

Publication number
DE60113895D1
DE60113895D1 DE60113895T DE60113895T DE60113895D1 DE 60113895 D1 DE60113895 D1 DE 60113895D1 DE 60113895 T DE60113895 T DE 60113895T DE 60113895 T DE60113895 T DE 60113895T DE 60113895 D1 DE60113895 D1 DE 60113895D1
Authority
DE
Germany
Prior art keywords
poultry
osteoporosis
prophylaxis
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60113895T
Other languages
English (en)
Other versions
DE60113895T2 (de
Inventor
Thierry Bardon
Dominique Thibaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of DE60113895D1 publication Critical patent/DE60113895D1/de
Application granted granted Critical
Publication of DE60113895T2 publication Critical patent/DE60113895T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60113895T 2000-01-12 2001-01-11 Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose Expired - Fee Related DE60113895T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000356 2000-01-12
FR0000356A FR2803521B1 (fr) 2000-01-12 2000-01-12 Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose

Publications (2)

Publication Number Publication Date
DE60113895D1 true DE60113895D1 (de) 2006-02-23
DE60113895T2 DE60113895T2 (de) 2006-06-22

Family

ID=8845841

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113895T Expired - Fee Related DE60113895T2 (de) 2000-01-12 2001-01-11 Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose

Country Status (15)

Country Link
US (1) US6482809B1 (de)
EP (1) EP1129714B1 (de)
JP (1) JP2001199891A (de)
AT (1) ATE306273T1 (de)
AU (1) AU783667B2 (de)
CZ (1) CZ2001135A3 (de)
DE (1) DE60113895T2 (de)
DK (1) DK1129714T3 (de)
ES (1) ES2249396T3 (de)
FR (1) FR2803521B1 (de)
HU (1) HUP0100122A3 (de)
IL (1) IL140839A0 (de)
NZ (1) NZ509285A (de)
SK (1) SK286583B6 (de)
ZA (1) ZA200100289B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301143B6 (cs) * 2005-03-10 2009-11-18 Koropecký@Igor Zpusob získávání koncentrovaného glycerolu a smesi vyšších mastných kyselin z glycerinové fáze, vznikající pri výrobe bionafty

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
EP0950417A3 (de) * 1998-02-23 2000-02-23 Pfizer Products Inc. Behandlung von Skeletterkrankungen
WO2000064516A1 (en) * 1999-04-22 2000-11-02 Hydromed Sciences A Division Of Gp Strategies Corporation Controlled delivery of bisphosphonates

Also Published As

Publication number Publication date
HU0100122D0 (en) 2001-03-28
ZA200100289B (en) 2001-07-24
SK552001A3 (en) 2001-08-06
JP2001199891A (ja) 2001-07-24
EP1129714B1 (de) 2005-10-12
FR2803521B1 (fr) 2002-10-25
HUP0100122A2 (hu) 2002-03-28
DE60113895T2 (de) 2006-06-22
IL140839A0 (en) 2002-02-10
AU783667B2 (en) 2005-11-24
HUP0100122A3 (en) 2003-02-28
DK1129714T3 (da) 2006-02-06
ES2249396T3 (es) 2006-04-01
AU1114101A (en) 2001-07-19
US6482809B1 (en) 2002-11-19
CZ2001135A3 (cs) 2001-08-15
EP1129714A1 (de) 2001-09-05
FR2803521A1 (fr) 2001-07-13
SK286583B6 (sk) 2009-01-07
NZ509285A (en) 2002-05-31
ATE306273T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
DE60117043D1 (de) Behandlung von mukositis
BR0116832A (pt) Produto desodorante, método cosmético e método de fabricação de composição desodorante
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
DE69826023D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
SE0102887D0 (sv) New formulation
DE60106890D1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
DE69930624D1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
DE60112253D1 (de) Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose
HUP0202791A2 (hu) Pikkelysömör kezelésére alkalmas gyógyszerkészítmények
ES2173044A1 (es) Glicina, n-(n-l- -glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee